Publications
2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profifiling and chemical proteomics in chronic myeloid leukemia cells.
Rix U,
Remsing Rix LL,
Terker AS,
Fernbach NV,
Hantschel O,
Planyavsky M,
Breitwieser FP,
Herrmann H,
Colinge J,
Bennett KL,
Augustin M,
Till JH,
Heinrich MC,
Valent P,
Superti-Furga G.
Leukemia, Epub 2009 Nov 5.
2009
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
Remsing Rix LL,
Rix U,
Colinge J,
Hantschel O,
Bennett KL,
Stranzl T,
Müller A,
Baumgartner C,
Valent P,
Augustin M,
Till JH,
Superti-Furga G.
Leukemia, 2009 Mar;23(3):477-85.
2009
Activation of MDA5 requires higher-order RNA structures generated during virus infection.
Pichlmair A,
Schulz O,
Tan CP,
Rehwinkel J,
Kato H,
Takeuchi O,
Akira S,
Way M,
Schiavo G,
Reis e Sousa C.
J Virol, 2009 Oct;83(20):10761-9. Epub 2009 Aug 5.
2009
The TLR independent DNA recognition pathway in murine macrophages: Ligand features and molecular signature.
Karayel E,
Bürckstümmer T,
Weitzer S,
Martinez J,
Superti-Furga G.
Eur J Immunol, 2009 Jul;39(7):1929-36.
2009
NSs protein of rift valley fever virus induces the specific degradation of the double stranded RNA-dependent protein kinase.
Habjan M,
Pichlmair A,
Elliott RM,
Overby AK,
Glatter T,
Gstaiger M,
Superti-Furga G,
Unger H,
Weber F.
J Virol, 2009 May;83(9):4365-75. Epub 2009 Feb 11.
2009
Acid elution and one-dimensional shotgun analysis on an orbitrap mass spectrometer – an application to drug affifinity chromatography.
Fernbach NV,
Planyavsky M,
Müller A,
Breitwieser FP,
Colinge J,
Rix U,
Bennett KL.
J 2009 Oct;8(10):4753-65.Proteome Res,.
2009
An orthogonal proteomic-genomic screen identififies AIM2 as a cytoplasmic DNA sensor for the inflammasome.
Bürckstümmer T,
Baumann C,
Blüml S,
Dixit E,
Dürnberger G,
Jahn H,
Planyavsky M,
Bilban M,
Colinge J,
Bennett KL,
Superti-Furga G.
Nat Immunol, 2009 Mar;10(3):266-72. Epub 2009 Jan 21.
2009
Intercell – accelerating innovation.
Brehme M.
N Biotechnol, 2009 Apr;25(4):181-4. Epub 2009 Feb 21.
2009
Charting the molecular network of the drug target Bcr-Abl.
Brehme M,
Hantschel O,
Colinge J,
Kaupe I,
Planyavsky M,
Köcher T,
Mechtler K,
Bennett KL,
Superti-Furga G.
Proc Natl Acad Sci USA, 2009 May 5;106(18): 7414-9. Epub 2009 Apr 20.
2009
Report on EU-USA workshop: how systems biology can advance cancer research
Aebersold R,
Auffray C,
.
Mol Oncol, 2009 Feb;3(1):9-17.
